产品封面图

Cdc22 / RMM1 (S. pombe) antibo

dy
收藏
  • ¥5600
  • GeneTex已认证
  • 美国
  • GTX64099
  • 2025年12月26日
  • WB
  • Rabbit
  • Schizosaccharomyces pombe
avatar
品牌商
14钻石会员
  • 企业认证

    点击 QQ 联系

  • 万千商家帮你免费找货

    0 人在求购买到急需产品
    • 详细信息
    • 文献和实验
    • 技术资料
    • 免疫原

      Synthetic peptide, NVNPTDLWDWAE-C, corresponding to 571-582 residues of S. pombe Cdc22 protein.

    • 亚型

      IgG

    • 形态

      Liquid

    • 保存条件

      Store as concentrated solution. Centrifuge briefly prior to opening vial. For short-term storage (1-2 weeks), store at 4ºC. For long-term storage, aliquot and store at -20ºC or below. Avoid multiple freeze-thaw cycles.

    • 克隆性

      Polyclonal

    • 标记物

      Unconjugated

    • 适应物种

      Schizosaccharomyces pombe

    • 保质期

      12 months from the shipping date of the product. 

    • 抗原来源

      Yeast

    • 目录编号

      GTX64099

    • 级别

      Primary Antibodies

    • 库存

      Available

    • 供应商

      GeneTex

    • 宿主

      Rabbit

    • 应用范围

      WB

    • 浓度

      Batch dependent (Please refer to the vial label for the specific concentration.)

    • 靶点

      Cdc22 / RMM1 (S. pombe)

    • 抗体英文名

      Cdc22 / RMM1 (S. pombe) antibody

    • 抗体名

      Cdc22 / RMM1 (S. pombe) 抗体

    • 规格

      100 μg

    产品细节图片1

    Western blot analysis with Cdc22 antibody. Cdc22 protein (92 kDa) was detected by western blotting in S. pombe crude extract. 7.5 % SDS-PAGE was used. Anti-Cdc22 antibody was used at 1/1,000 dilution and and secondary antibody, anti-rabbit IgG conjugated with HRP, was used at 1/10,000 ditluion.

    风险提示:丁香通仅作为第三方平台,为商家信息发布提供平台空间。用户咨询产品时请注意保护个人信息及财产安全,合理判断,谨慎选购商品,商家和用户对交易行为负责。对于医疗器械类产品,请先查证核实企业经营资质和医疗器械产品注册证情况。

    图标文献和实验
    相关实验
    • Anti-CD22 Onconase: Preparation and Characterization

      Antibodies can be conjugated to effector molecules to derive targeted therapeutics with properties such as cell-specific cytotoxicity. The murine anti-CD22 antibody RFB4 linked to a member of the ribonuclease A superfamily, Onconase (Onc

    • 【翻译】Development trends for monoclonal antibody cancer therapeutics

      has more than tripled since the 1980s, from 4.3 per year in the 1980s to 8.3 per year in the 1990s and 13.3 per year for 2000–2005. One reason for the increased investment in mAbs was the evolution of the discovery technology. The initial method for producing mAbs

    • monoclonal antibody production fusion

      ), 3 L, 0.22 (or 0.45) µm-filtered, store at -20ѓC =  Asp-Arg x100, 1 L + Gluta x 50, 2 L + mercaptoethanol, 350 µl Asp-Arg x100, 1 L, pH 6.0 = L-Asparagine, 3.6 g (0.24 mM) + L-Arginine (0.55 mM), 11.6 g + HCl, 0.5N, 100 ml -> heat to 37ѓC

    图标技术资料

    暂无技术资料 索取技术资料

    同类产品报价

    产品名称
    产品价格
    公司名称
    报价日期
    ¥5600
    深圳欣博盛生物科技有限公司
    2025年07月07日询价
    ¥5600
    GeneTex
    2025年07月24日询价
    ¥550
    上海联迈生物工程有限公司
    2025年06月15日询价
    ¥440
    武汉华美生物工程有限公司CUSABIO®
    2025年07月08日询价
    Cdc22 / RMM1 (S. pombe) antibody
    ¥5600